Taiga Biotechnologies' Grant

Taiga Biotechnologies raised a round of funding on October 26, 2010. Investors include National Institutes of Health.

Taiga Biotechnologies is a privately held developer of novel therapies for complex diseases including cancers, infectious agents such as HIV and influenza, and hematologic conditions. Each of the comp…

Articles about Taiga Biotechnologies' Grant: